SEMA3C and breast carcinoma: Based on our previous report, which suggested that SEMA3C transactivates multiple RTKs through its interaction with Plexin B1, we conducted plexin B1 silencing experiments to investigate whether SEMA3C drives signaling through Plexin B1 in ER+ breast cancer.